CHARTING YOUR COURSE TO BIOTECH SUCCESS

From Discovery to Deal, One Platform

The biotech ecosystem's trusted infrastructure for capital raising, licensing partnerships, and grant discovery. Verified connections. Structured data. Real deals.

I AM A…

FREE TO JOIN · NO SUBSCRIPTIONS · FEES ONLY ON SUCCESS
PROGRAM · SMALL MOLECULE → IND ● ON COURSE
Q1Q2Q3Q4Q5Q6Q7Q8
DISCOVERY
100%
PRECLINICAL
100%
IND-ENABLING
CMC
REGULATORY
CLINICAL PH 1
92% Meridian Bio CapitalSeries A · Oncology · match score
IND filing — on course
€2.4B+
Total Funding Tracked
1,200+
Verified Members
340+
Active Companies
89%
Match Quality
◈ ONENDA CDAs

Industry-standard confidentiality agreements with jurisdiction choice (England & Wales or New York). One click to protect your IP.

◈ VERIFIED PROFILES

Three-tier verification: email (auto), LinkedIn (manual), company registration (admin-approved). Know who you're talking to.

◈ LEAKAGE PREVENTION

Automated detection blocks phone numbers, personal emails, and LinkedIn URLs in messages. Keep sensitive conversations on-platform.

◈ ALIGNED INCENTIVES

No subscriptions. No listing fees. Biochart earns only when your deal succeeds.

FOUR SIDES OF THE DEAL

Built for Everyone in Biotech

Four distinct journeys. One powerful platform.

01 · FOUNDER

For Founders

Raise capital faster with structured data that investors trust. No more pitch deck roulette.

  • Gantt-powered roadmaps show investors exactly where you are and where you're going
  • AI-matched investors with proven track records in your therapeutic area
  • One-click CDAs protect your IP while opening conversations
  • Syndication tools let lead investors bring co-investors to your round
Get started as a Founder
02 · INVESTOR

For Investors

Discover pre-vetted opportunities with the data you need to decide. No more cold inbound.

  • Weighted match scores surface the deals that fit your thesis
  • Structured profiles standardize data across companies for easy comparison
  • Saved searches alert you when new companies match your criteria
  • Lead rounds and bring co-investors with built-in syndication
Get started as an Investor
03 · BD&L

For BD & Licensing

Source licensing deals and partnership opportunities without the conference circuit.

  • Curated deal flow filtered by therapeutic area and development stage
  • Development timelines visualized in Gantt charts for easy due diligence
  • Secure conversations gated behind CDAs to protect both parties
  • IP details and regulatory status clearly documented
Get started in BD & Licensing
04 · GRANT SPECIALIST

For Grant Specialists

Connect companies with non-dilutive funding opportunities at scale.

  • Qualified leads actively seeking non-dilutive funding
  • Detailed profiles with therapeutic area, stage, and funding needs
  • Discovery tools to filter companies by grant eligibility
  • Track record showcase your success rate and specialty areas
Get started as a Grant Specialist
THE COURSE

How Biochart Works

From profile to partnership in three steps.

01
WAYPOINT · PROFILE

Create Your Profile

Build a structured profile with the data that matters. Founders add development timelines. Investors specify investment thesis. BD&L teams outline partnership criteria.

02
WAYPOINT · MATCH

Discover Matches

Our AI ranks connections by therapeutic area, stage, geography, and deal size. Save searches to get alerts when new opportunities appear.

30%
25%
20%
15%
10%
Therapeutic area Stage Geography Deal type Modality
03
WAYPOINT · CONNECT

Sign CDA & Connect

One-click CDAs protect sensitive information. Once signed by both parties, full details unlock and secure messaging opens.

BEFORE CDAIP status hidden · summary only
CDA SIGNEDClickwrap, both parties
AFTER CDAFull detail unlocked
THE DIFFERENCE

Why Biochart Beats the Old Way

10x Faster Than Conferences

No more waiting months for the next JPM or BIO. Connect with the right people today.

Built-in IP Protection

OneNDA-based CDAs protect sensitive information before conversations start. No manual paperwork.

Data That Investors Actually Want

Structured profiles with Gantt charts, IP status, and regulatory pathways. No more digging through 50-slide decks.

Verified Community

Tiered verification ensures you're talking to real decision-makers, not tire-kickers.

Program Status

GOALS VS. REALITY
IND filing — on course CMC batch — 2 wks behind Tox study — at risk
Current Stage: Preclinical
Next Milestone: IND Filing

Illustrative program view — variance tracked against goal dates.

CHART · YOUR AI COPILOT

A partnering strategist on every page.

Chart answers questions about your matches, your timeline, and your next move — grounded in your program's actual data.

C Chart ● ONLINE
Which matches should I prioritise this week?
Meridian Bio Capital is your strongest fit (92%) and viewed your profile twice this week. I'd start there — want a draft intro?
Yes — and flag anyone with EU presence.
YOUR COURSE STARTS HERE

Ready to Close Your
Next Deal Faster?

Join the biotech professionals already using Biochart

FREE TO JOIN NO SUBSCRIPTIONS FEES ONLY ON SUCCESS